Plain-English translation of NCT07001007 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new device that uses gentle vibrations to analyze blood flow in your arteries—a quick, safe way to check if your heart and blood vessels are aging well. Researchers want to see if this technology can better predict who is at risk for heart disease before symptoms appear, compared to current methods like heart scans that use radiation.
Many people have early signs of heart disease without any symptoms, but current screening methods either miss these signs or expose patients to radiation and other risks. This study exists to see whether this new device could offer a faster, safer way to catch heart disease risk early, when treatment is most effective.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will complete a quick, non-invasive scan using the new vibration-based device at Danderyd Hospital in Stockholm. The device gently analyzes your pulse waves to assess the stiffness and health of your arteries—no needles, no radiation, and no significant time commitment. This is part of a larger follow-up study of people who were first evaluated about 6–10 years ago.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
Sweden
HJN Sverige AB/Neko Health
Enrollment target
~1,600 participants
Started
July 2024
Primary completion
June 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
58 Years – 72 Years
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mattias Windå
Karolinska Institute, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.